Using secondary outcome to sharpen bounds for treatment harm rate in characterizing heterogeneity
From MaRDI portal
Recommendations
- Assessing the heterogeneity of treatment effects by identifying the treatment benefit rate and treatment harm rate
- Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect
- Assessing treatment effect heterogeneity in clinical trials with blocked binary outcomes
- Assessing the treatment effect heterogeneity with a latent variable
- Estimating treatment effect heterogeneity for binary outcomes via Dirichlet multinomial constraints
Cited in
(4)- Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect
- Assessing the heterogeneity of treatment effects by identifying the treatment benefit rate and treatment harm rate
- Assessing treatment effect heterogeneity in clinical trials with blocked binary outcomes
- Parametric inference for the Mann-Whitney effect under survival copula models
This page was built for publication: Using secondary outcome to sharpen bounds for treatment harm rate in characterizing heterogeneity
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4962944)